Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution

被引:18
作者
Botteri, E. [2 ,3 ]
Gentilini, O. [1 ]
Rotmensz, N. [2 ]
Veronesi, P. [1 ]
Ratini, S. [1 ]
Fraga-Guedes, C. [1 ]
Toesca, A. [1 ]
Sangalli, C. [1 ]
Del Castillo, A. [1 ]
Rietjens, M. [4 ]
Viale, G. [5 ,6 ]
Orecchia, R. [7 ]
Goldhirsch, A. [8 ]
Veronesi, U. [1 ]
机构
[1] European Inst Oncol, Div Senol, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy
[3] Univ Milan, Dept Occupat Hlth, Milan, Italy
[4] European Inst Oncol, Div Plast Surg, Milan, Italy
[5] European Inst Oncol, Div Pathol, Milan, Italy
[6] Univ Milan, Sch Med, Milan, Italy
[7] European Inst Oncol, Div Radiotherapy, Milan, Italy
[8] European Inst Oncol, Div Med Oncol, Milan, Italy
关键词
Breast cancer; Radiotherapy; Mastectomy; BREAST-CANCER PATIENTS; LOCOREGIONAL RECURRENCE; POSTMASTECTOMY RADIOTHERAPY; RISK-FACTORS; NODES; GUIDELINES; TUMORS;
D O I
10.1007/s10549-012-2044-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to identify the prognostic factors associated with the risk of loco-regional recurrence (LRR) of women undergoing mastectomy and complete axillary dissection without radiotherapy. We analyzed data from 650 women operated between 1997 and 2001 in a single institution. Median follow-up was 10 years. Overall survival was 89.8 % at 5 years and 76.6 % at 10 years. The 10-year cumulative incidence of LRRs was 10.0 % (5.0, 10.5, 15.8, and 18.5 % in patients with 0, 1-3, 4-9, and a parts per thousand yen10 positive lymph nodes (LNs), respectively). Sixty-two (9.5 %) LRRs were observed, 5 (0.8 %) of which occurred in the axillary LNs. Supraclavicular LNs recurrences (n = 16, 2.5 %) occurred more frequently in patients with four or more positive LNs, Ki-67 a parts per thousand yen 20 % or extensive peritumoral vascular invasion (PVI). At multivariable analysis, nodal status was the only prognostic factor for local events, while nodal status, Ki-67 and PVI were significant prognostic factors for recurrences in the regional LNs. Moreover, within each category of positive LNs, high values of Ki-67 and extensive PVI were associated with the highest risk of LRR while low values of Ki-67 and absence of extensive PVI were associated with the lowest risk of LRR. Women with node-negative tumors have the lowest risk of LRR and represent the group of patients that might benefit the least from radiotherapy. PVI and Ki-67 might help tailoring PMRT indications among patients with positive LNs. Finally, the very low incidence of recurrences in the axillary LNs raises questions about the inclusion of the axilla in the radiation field.
引用
收藏
页码:1221 / 1228
页数:8
相关论文
共 18 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   PATTERNS AND RISK FACTORS OF LOCOREGIONAL RECURRENCE IN T1-T2 NODE NEGATIVE BREAST CANCER PATIENTS TREATED WITH MASTECTOMY: IMPLICATIONS FOR POSTMASTECTOMY RADIOTHERAPY [J].
Abi-Raad, Rita ;
Boutrus, Rimoun ;
Wang, Rui ;
Niemierko, Andrzej ;
Smith, Barbara ;
Taghian, Alphonse G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03) :E151-E157
[3]  
BERG JW, 1955, CANCER-AM CANCER SOC, V8, P776, DOI 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO
[4]  
2-B
[5]   Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications [J].
Cowen, Didier ;
Gross, E. ;
Rouannet, P. ;
Teissier, E. ;
Ellis, S. ;
Resbeut, M. ;
Tallet, A. ;
Cowen, V. Vaini ;
Azria, D. ;
Hannoun-Levi, J. M. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (03) :627-634
[6]   Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution [J].
Gentilini, O. ;
Botteri, E. ;
Rotmensz, N. ;
Intra, M. ;
Gatti, G. ;
Silva, L. ;
Peradze, N. ;
Sahium, R. C. ;
Gil, L. B. ;
Luini, A. ;
Veronesi, P. ;
Galimberti, V. ;
Gandini, S. ;
Goldhirsh, A. ;
Veronesi, U. .
ANNALS OF ONCOLOGY, 2007, 18 (08) :1342-1347
[7]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[8]   Radiotherapy and tamoxifen after mastectomy in postmenopausal women -: 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I [J].
Killander, Fredrika ;
Anderson, Harald ;
Ryden, Stefan ;
Moller, Torgil ;
Aspegrend, Knut ;
Ceberg, Jeanette ;
Danewid, Christina ;
Malmstrom, Per .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (14) :2100-2108
[9]   CHEST WALL RADIOTHERAPY: MIDDLE GROUND FOR TREATMENT OF PATIENTS WITH ONE TO THREE POSITIVE LYMPH NODES AFTER MASTECTOMY [J].
MacDonald, Shannon M. ;
Abi-Raad, Rita F. ;
El-Din, Mohamed A. Alm ;
Niemierko, Andrzej ;
Kobayashi, Wendy ;
McGrath, John J. ;
Goldberg, Saveli I. ;
Powell, Simon ;
Smith, Barbara ;
Taghian, Alphonse G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05) :1297-1303
[10]  
National Institutes of Health Consensus Development Panel, 2001, J Natl Cancer Inst Monogr, P5